Endovia Health Sciences, Inc.

US$0.19As of Sun 8 Nov 2026, 12:00 UTC
AMEX:EDVAHealthcare
Country USA
PE (Fwd) •••
TSR 7Y CAGR (66.32%)
Div yield —
ROE —
Biotechnology
Beta (5Y) (1.11)
PE TTM —
TSR TTM (97.09%)
Mkt cap US$1.218M
ROIC (503.14%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
$0.23
21.06%
259.00%
Hold 12|12|6|7|12
4Q25
1Q26
2Q26
3Q26
Earnings per share$
—
—
—
—
37.50%
19.51%
10.75%
2.48%
Revenue$M
0.065
0.065
0.064
0.062
(2.50%)
(2.42%)
(2.71%)
(4.18%)
Peers (US$1.218M)
Cap (US$)
PE
1.303M
—
1.130M
—
Capital
TTM
5Y
10Y
Leveragex
0.934
0.121
0.112
EBIT/Intx
6.325
0.214
0.161
Own earn%
60.05
3.25
3.26
Sh yield%
16.61
59.43
53.93
Owners
Insiders/Inst%
14.17
45.81
Short interest%
1.22
SBC / revenue%
4.63
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
17
Op margin range%
0–5
$1 testx
0.2
Incr. ROIC%
38